" As MBA professors endlessly tell their students, companies do best when they stick to what they do well. There’s a reason Apple doesn’t make blenders. There’s a reason Haagen-Dazs doesn’t sell meat. And there’s a reason drug companies should focus on saving and improving lives – not jeopardizing them. "
- Jeffrey Kluger

In today's competitive business landscape, companies are often advised to focus on their core competencies and stay within their areas of expertise. This means that successful firms tend to avoid venturing into unrelated industries where they lack knowledge or experience. For example, Apple is renowned for its innovative technology products but doesn't manufacture kitchen appliances like blenders, while Haagen-Dazs focuses solely on producing high-quality ice cream rather than diversifying into meat sales.

The deeper meaning of this advice suggests that staying true to one's strengths can lead to greater success and market leadership. Companies should invest in what they do best and refrain from diluting their efforts across multiple unrelated ventures, which could potentially harm their reputation or reduce the quality of their products and services. In Kluger’s context, he is highlighting how drug companies should prioritize research, development, and marketing of medicines that enhance and save lives, rather than engaging in activities that might compromise public health.

Jeffrey Kluger, a respected journalist and author, often delves into topics related to science, technology, and business ethics. His insights are widely read due to their clarity and relevance, making him an influential voice on how companies should operate within ethical boundaries while pursuing profit.